Frazier Life Sciences Management, L.P.
PALO ALTO, CA · CIK 1892134 · 13F filing filed 2023-08-14
SEC-registered investment adviser since 2021 · limited partnership
- Assets managed$7.0bn
- Staff64 · 47 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds8 (1 hedge) · $7.0bn gross assets
- Websitefrazierls.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityFrazier Life Sciences Management, L.P. (US)
- Kindhedge funds, private equity, venture
- Others nearbyPalo Alto, CA, San Diego, CA
As an employer
- Offices in1 country
- Private fundsventure capital 4, hedge 1, private equity 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Palo Alto, CA (main office)United States | about 44 |
| San Diego, CAUnited States | 3 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$1.7bn
reported value
+21.2% vs Q1 2023
48positions
66.8%in top 10
4 new
12 added
8 reduced
5 sold out
vs Q1 2023
Holdings, Q2 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| HILLEVAX INC COM | $168.1m10.04% | Unchanged |
| CHINOOK THERAPEUTICS INC ADRO | $167.0m9.97% | Unchanged |
| PHATHOM PHARMACEUTICALS INC PHAT | $144.8m8.65% | Added +1.7m |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $129.3m7.72% | Added +1.5m |
| KRYSTAL BIOTECH INC KRYS | $116.3m6.94% | Added +44.9k |
| MIRUM PHARMACEUTICALS INC MIRM | $112.8m6.74% | Added +500.0k |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $82.8m4.94% | Unchanged |
| SYNDAX PHARMACEUTICALS INC SNDX | $77.6m4.64% | Unchanged |
| VERONA PHARMA PLC VRNA | $62.2m3.72% | Unchanged |
| VAXCYTE INC PCVX | $58.2m3.47% | Reduced -233.0k |
| RHYTHM PHARMACEUTICALS INC RYTM | $35.7m2.13% | Added +2.5k |
| BRIDGEBIO PHARMA INC BBIO | $34.2m2.04% | Added +817.2k |
| TARSUS PHARMACEUTICALS INC TARS | $32.3m1.93% | Unchanged |
| ALPINE IMMUNE SCIENCES INC NVLS | $30.7m1.83% | Unchanged |
| KALVISTA PHARMACEUTICALS INC KALV | $29.1m1.74% | Unchanged |
| DISC MEDICINE INC IRON | $29.1m1.74% | New |
| CRINETICS PHARMACEUTICALS IN CRNX | $25.5m1.52% | Unchanged |
| REVOLUTION MEDICINES INC RVMD | $22.9m1.37% | Unchanged |
| THESEUS PHARMACEUTICALS INC COM | $21.0m1.25% | Unchanged |
| ACADIA PHARMACEUTICALS INC ACAD | $20.5m1.23% | Unchanged |
| MERUS N V MRUS | $19.7m1.17% | Unchanged |
| ANAPTYSBIO INC ANAB | $18.3m1.09% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $17.8m1.06% | Reduced -657.8k |
| TYRA BIOSCIENCES INC TYRA | $17.5m1.05% | Reduced -393.3k |
| AEROVATE THERAPEUTICS INC COM | $17.1m1.02% | Added +656.7k |
| ENLIVEN THERAPEUTICS INC ELVN | $17.0m1.01% | Unchanged |
| ORIC PHARMACEUTICALS INC ORIC | $16.6m0.99% | New |
| TREVI THERAPEUTICS INC TRVI | $16.4m0.98% | Added +217.5k |
| MORPHIC HLDG INC MORF | $15.2m0.91% | Added +51.3k |
| CEREVEL THERAPEUTICS HLDNG I CERE | $12.5m0.75% | Unchanged |
| REATA PHARMACEUTICALS INC RETA | $10.2m0.61% | New |
| MACROGENICS INC MGNX | $9.6m0.58% | Added +100.0k |
| REPLIMUNE GROUP INC REPL | $9.0m0.54% | Reduced -300.0k |
| AUTOLUS THERAPEUTICS PLC AUTL | $8.9m0.53% | Unchanged |
| PROTHENA CORP PLC PRTA | $8.7m0.52% | Unchanged |
| INTELLIA THERAPEUTICS INC NTLA | $8.3m0.50% | Unchanged |
| ARVINAS INC ARVN | $7.1m0.42% | Unchanged |
| EDGEWISE THERAPEUTICS INC EWTX | $5.8m0.35% | Added +66.6k |
| IMMUNOVANT INC IMVT | $5.7m0.34% | Reduced -285.8k |
| BLUEBIRD BIO INC COM | $5.6m0.34% | Added +269.1k |
| DECIPHERA PHARMACEUTICALS IN DCPH | $5.2m0.31% | New |
| SILENCE THERAPEUTICS PLC SLN | $4.8m0.29% | Unchanged |
| GRITSTONE BIO INC GRTS | $4.7m0.28% | Reduced -2.8m |
| SUTRO BIOPHARMA INC COM | $3.6m0.22% | Reduced -996.5k |
| ADC THERAPEUTICS SA ADCT | $3.5m0.21% | Unchanged |
| ACLARIS THERAPEUTICS INC ACRS | $2.7m0.16% | Unchanged |
| PASSAGE BIO INC COM | $1.7m0.10% | Reduced -1.9m |
| NEWAMSTERDAM PHARMA COMPANY NAMSW | $1.0m0.06% | Unchanged |
Sold out since Q1 2023
| Security | Value then |
|---|---|
| VECTIVBIO HLDG AG | $11.6m1.4m shares |
| AVIDITY BIOSCIENCES INC RNA | $7.7m500.0k shares |
| ZYMEWORKS INC ZYME | $5.5m610.0k shares |
| ALLAKOS INC ALLKG | $5.0m1.1m shares |
| NABRIVA THERAPEUTICS PLC NBRVF | $29.7k17.0k shares |